Healthy Control clinical trials

Explore recruiting healthy control clinical trials.

Recruiting healthy control studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Healthy Control trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

eGPA and local inflammation within the ENT area; Impact of Mepolizumab treatment on the nasal microbiome and local and systemic immune response in eosinophilic granulomatosis with polyangitis (eGPA)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A clinical phase IV trial to examine cellular and humoral immunity against measles and chickenpox in children and adolescents 0-18 years in childhood cancer.

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

OBEVIDOS “Treatment of vitamin D deficit in obese children and adolescents: an open label randomized controlled study comparing the efficacy of two oral supplementation regimens: monthly boluses versus daily doses for correcting blood vitamin D level.”

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Immunogenicity and safety of a meningococcal serogroup B vaccine in adult patients with asplenia

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase-2b controlled study to evaluate the humoral and cellular immune response and safety following one and two doses of an adjuvanted RSV subunit vaccine in immunocompromised patients aged 18 years and older.

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

A Single-Blind randomized trial of High-Dose versus Standard-Dose Inactivated Influenza Vaccine in Adult Patients Treated for an Hematological Cancer (Flu-Hemato-Rando study)

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Healthy Control trials by city

Healthy Control in Toronto Healthy Control in Vancouver Healthy Control in Montreal Healthy Control in Calgary Healthy Control in Edmonton Healthy Control in Ottawa Healthy Control in Winnipeg Healthy Control in Quebec City Healthy Control in Hamilton Healthy Control in Kitchener Healthy Control in London Healthy Control in Halifax Healthy Control in New York Healthy Control in Los Angeles Healthy Control in Chicago Healthy Control in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease